Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1722671000168119 | Sandostatin LAR (inert substance) diluent [1 x 2 mL syringe] (&) (octreotide 10 mg) modified release injection [1 x 10 mg vial], 1 pack (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1722681000168116 | Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Is a | trade product pack | true | Inferred relationship | Some | ||
Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Is a | octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack | true | Inferred relationship | Some | ||
Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | has TPUU | Sandostatin LAR (octreotide 10 mg) modified release injection, 10 mg vial | true | Inferred relationship | Some | 1 | |
Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | has TPUU | Sandostatin LAR (inert substance) diluent, 2 mL syringe | true | Inferred relationship | Some | 2 | |
Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | has TP | Sandostatin LAR | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Is a | True | Sandostatin LAR (1 x 10 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | Inferred relationship | Some |
Reference Sets
Trade product pack reference set